Navigation Links
Tunnell Consulting to Partner with Pharma Quality and Compliance Expert Dr. Ali Afnan
Date:1/22/2013

King of Prussia, PA (PRWEB) January 22, 2013

Tunnell Consulting, Inc. today announced that it has formed a partnership with Ali Afnan, PhD, President of Step Change Pharma, a life sciences consultancy working at the intersection of regulatory compliance and pharmaceutical science.

An expert in compliance and quality, Dr. Afnan was recruited in 2003 by the FDA’s Center for Drug Evaluation and Research (CDER) to join the agency’s Process Analytical Technology (PAT) and Drug Product Quality initiatives. As a member of the PAT steering team and as the science policy advisor to the Office of Pharmaceutical Science, he co-authored the agency’s PAT Guidance and helped draft its most recent guidance on process validation.

“Dr. Afnan’s experience at the FDA enables him to provide life sciences clients with an invaluable perspective on technical and regulatory compliance matters. His demonstrated expertise in compliance, Quality by Design and pharmaceutical science complements Tunnell’s longstanding strengths in those critical areas,” said Conrad J. Heilman, Jr., PhD, President and CEO of Tunnell. “As partners, our combined technical skills and regulatory compliance knowledge will offer both Tunnell and Step Change clients’ unparalleled resources for achieving excellence in their operations.”

“I am delighted to partner with Tunnell, with its proven methodologies and long track record of delivering sustainable solutions to leading pharmaceutical companies,” said Dr. Afnan. “Together we will be able to help clients succeed in an increasingly science-driven regulatory environment where compliance and quality have become essential elements of competitiveness.”

The recipient of several FDA and CDER awards, Dr. Afnan left the agency in 2010 and founded Step Change. Dr. Afnan was the recipient of the 2012 IPS Medal for contributions to Industrial Pharmacy from International Pharmaceutical Federation, and he is a frequent speaker at major industry conferences.

About Tunnell Consulting
Founded in 1962 and serving many of the world’s leading life sciences firms and government agencies, Tunnell Consulting, Inc. integrates strategic, technical and regulatory compliance skills to design and implement sustainable solutions that exactly meet client needs. With deep industry knowledge, extensive scientific and compliance credentials, and superior measurable results, we consistently boost the operating performance of each unique client we serve.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10328058.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
2. A leading Massachusetts-based IT and Life Sciences staffing and consulting firm has opened two new offices in the Ohio Valley
3. No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
4. EAS Consulting Group Realigns Its Management for Growth
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
7. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. Pittcon and Food Safety Tech Announce Strategic Conference Partnership
10. Direct Marketing Partners Wins Sales Lead Management’s “Most Influential” in 2012
11. RegLink News Partners with FOI Services on Off-Label Use Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
(Date:3/23/2017)... March 23, 2017 In today,s ... equities in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: ... (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market ... free report at: ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... 2017 Good Start Genetics, a leading family ... 130 million covered lives mark through its most recent ... Texas . With newly signed contracts nationally and ... strong payor acceptance based on the quality of its ... counseling, its industry-leading customer care and support and its ...
Breaking Biology Technology:
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
(Date:2/22/2017)... With the biometrics market to exceed ... technologies that innovative and agile startups must incorporate ... the changing competitive landscape: multifactor authentication (MFA), point-of-sale ... "Companies can no longer afford to cut ... Dimitrios Pavlakis , Industry Analyst at ABI Research. ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):